/Companies

Esanik Therapeutics

Malvern, US · Delaware corporation

Find your way into Esanik Therapeutics

Sign up to see every warm intro you have to Esanik Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Esanik Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JM
John Mel SorensenExecutive

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 2 rounds · 2024–2026

▶$200KraisedApr 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John Mel SorensenExecutive Officer, Director
Offering amount
$375K
Amount sold
$200K
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedNov 2024 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John Mel SorensenExecutive Officer
Offering amount
$3.3M
Amount sold
$3.3M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Esanik Therapeutics raised?
Esanik Therapeutics has disclosed $3.5M raised across 2 rounds.
Where is Esanik Therapeutics headquartered?
Esanik Therapeutics is headquartered in Malvern, US.